Cargando…

Oral magnesium supplements for cancer treatment‐induced hypomagnesemia: Results from a pilot randomized trial

BACKGROUND AND AIMS: Optimal management of cancer treatment‐induced hypomagnesemia (hMg) is not known. We assessed the feasibility of using a novel pragmatic clinical trials model to compare two commonly used oral Mg replacement strategies. METHODS: Patients with grade 1 to 3 hMg while receiving eit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awan, Arif, Basulaiman, Bassam, Stober, Carol, Clemons, Mark, Fergusson, Dean, Hilton, John, Al Ghareeb, Waleed, Goodwin, Rachel, Ibrahim, Mohammed, Hutton, Brian, Vandermeer, Lisa, Mallick, Ranjeeta, Vickers, Michael M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669698/ https://www.ncbi.nlm.nih.gov/pubmed/34938893 http://dx.doi.org/10.1002/hsr2.443

Ejemplares similares

Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)
por: Hilton, John, et al.
Publicado: (2018)

A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer
por: Dent, Susan, et al.
Publicado: (2021)

A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia
por: Clemons, Mark, et al.
Publicado: (2021)

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer
por: Awan, Arif, et al.
Publicado: (2020)

Magnesium: The Forgotten Electrolyte—A Review on Hypomagnesemia
por: Ahmed, Faheemuddin, et al.
Publicado: (2019)

Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review
por: Fernandes, Ricardo, et al.
Publicado: (2017)

Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation
por: McGee, Sharon, et al.
Publicado: (2021)

Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
por: Zghoul, Nadia, et al.
Publicado: (2018)

Compounded Effervescent Magnesium for Familial Hypomagnesemia: A Case Report
por: Bennati, Giada, et al.
Publicado: (2023)

Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation
por: Stefanelli, Lucia Federica, et al.
Publicado: (2023)

A Randomized Controlled Trial Comparing Alloderm-RTU with DermACELL in Immediate Subpectoral Implant-Based Breast Reconstruction
por: Arnaout, Angel, et al.
Publicado: (2020)

Effect of Oral Magnesium Oxide Supplementation on Cisplatin-Induced Hypomagnesemia in Cancer Patients: A Randomized Controlled Trial
por: ZARIF YEGANEH, Maryam, et al.
Publicado: (2016)

Subcutaneous Magnesium Sulfate to Correct High-Output Ileostomy-Induced Hypomagnesemia
por: Makowsky, Mark J., et al.
Publicado: (2019)

Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
por: Tokarski, Rebecca M., et al.
Publicado: (2023)

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
por: Clemons, Mark, et al.
Publicado: (2021)

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey
por: AlZahrani, Mashari, et al.
Publicado: (2020)

Comparison of the Efficacy of Oral versus Intravascular Magnesium in the Prevention of Hypomagnesemia and Arrhythmia after CABG
por: Jannati, Mansour, et al.
Publicado: (2018)

Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
por: McGee, Sharon, et al.
Publicado: (2021)

A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting
por: Clemons, M., et al.
Publicado: (2020)

Hypomagnesemia in Brachycephalic Dogs
por: Mellema, M.S., et al.
Publicado: (2014)

Doxorubicin Loaded Magnesium Oxide Nanoflakes as pH Dependent Carriers for Simultaneous Treatment of Cancer and Hypomagnesemia
por: Ranathunge, Tharindu A., et al.
Publicado: (2019)

285 Renal Magnesium Wasting Post COVID-19 Infection: A Possible Unrecognized Cause of Hypomagnesemia
Publicado: (2023)

Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer
por: Tu, Megan M., et al.
Publicado: (2021)

Optimising weight-loss interventions in cancer patients—A systematic review and network meta-analysis
por: LeVasseur, Nathalie, et al.
Publicado: (2021)

Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program
por: Alshamsan, Bader, et al.
Publicado: (2022)

A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer
por: Hutton, Brian, et al.
Publicado: (2013)

Incidence of hypomagnesemia in the emergency room
por: Oliveira-Neto, PR, et al.
Publicado: (2003)

Hypomagnesemia: a clinical perspective
por: Pham, Phuong-Chi T, et al.
Publicado: (2014)

Prevention of Hypomagnesemia in Diabetes Patients
por: Madihi, Yahya, et al.
Publicado: (2013)

Hypomagnesemia in critically ill patients
por: Hansen, Bent-Are, et al.
Publicado: (2018)

Hypomagnesemia and hypokalemia: a successful oral therapeutic approach after 16 years of potassium and magnesium intravenous replacement therapy
por: Naljayan, Mihran, et al.
Publicado: (2014)

Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer
por: Clemons, Mark, et al.
Publicado: (2021)

Clinical Practice Guidelines and Consensus Statements in Oncology – An Assessment of Their Methodological Quality
por: Jacobs, Carmel, et al.
Publicado: (2014)

De-escalated administration of bone-targeted agents in patients with breast and prostate cancer—A survey of Canadian oncologists
por: Hutton, Brian, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Hypomagnesemia in type 2 diabetes mellitus
por: Dasgupta, Arundhati, et al.
Publicado: (2012)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Hypomagnesemia in Critically Ill Sepsis Patients
por: Velissaris, Dimitrios, et al.
Publicado: (2015)

Association of Hypomagnesemia with Hypocalcemia after Thyroidectomy
por: Chincholikar, Shrikanth P., et al.
Publicado: (2018)

Famotidine induced hypomagnesemia leading to hypocalcemia
por: Essrani, Rajesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g8b0vnl92l71t4pvcuj64jsdjb